Detailed Information on Publication Record
2006
Determination of midazolam and its metabolites in rat plasma and perfuse medium by HPLC
JUŘICA, Jan, Josef TOMANDL, Miroslav DOSTÁLEK and Eva HADAŠOVÁBasic information
Original name
Determination of midazolam and its metabolites in rat plasma and perfuse medium by HPLC
Name in Czech
Stanovení midazolamu a jeho metabolitů v potkaní plazmě a perfuzním médiu pomocí HPLC
Authors
JUŘICA, Jan, Josef TOMANDL, Miroslav DOSTÁLEK and Eva HADAŠOVÁ
Edition
Belgium, CD of the abstracts of the 29th international symposium on capillary chromatography, p. -, 1 pp. 2006
Publisher
T. Sandra, Research Institute for Chromatography
Other information
Language
English
Type of outcome
Stať ve sborníku
Field of Study
10600 1.6 Biological sciences
Country of publisher
Italy
Confidentiality degree
není předmětem státního či obchodního tajemství
Organization unit
Faculty of Medicine
Keywords in English
Cytochrome P450; Midazolam; 1 Hydroxymidazolam; 4 Hydroxymidazolam; 1 4 Dihydroxymidazolam; Rat; Perfuzate; Plasma
Tags
Tags
International impact
Změněno: 7/12/2006 11:44, doc. PharmDr. Jan Juřica, Ph.D.
V originále
A new isocratic reverse-phase high-performance liquid chromatography utilising ultraviolet detection for the simultaneous determination of midazolam and its three main hydroxymetabolites in rat plasma and rat liver perfuse medium is described. The present method offers various advantages over the currently used HPLC methods, including speed, sensitivity and reproducibility. Moreover, it may be applicable for modelling and description of possible pharmacological interactions on rat or human isoforms of cytochrome P450.
In Czech
A new isocratic reverse-phase high-performance liquid chromatography utilising ultraviolet detection for the simultaneous determination of midazolam and its three main hydroxymetabolites in rat plasma and rat liver perfuse medium is described. The present method offers various advantages over the currently used HPLC methods, including speed, sensitivity and reproducibility. Moreover, it may be applicable for modelling and description of possible pharmacological interactions on rat or human isoforms of cytochrome P450.
Links
GA203/06/0047, research and development project |
| ||
LC06023, research and development project |
| ||
MSM0021622404, plan (intention) |
|